Cargando…
Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage
NSAIDs are among the most commonly used drugs worldwide and their beneficial therapeutic properties are thoroughly accepted. However, they are also associated with gastrointestinal (GI) adverse events. NSAIDs can damage the whole GI tract including a wide spectrum of lesions. About 1 to 2% of NSAID...
Autores principales: | Sostres, Carlos, Gargallo, Carla J, Lanas, Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890944/ https://www.ncbi.nlm.nih.gov/pubmed/24267289 http://dx.doi.org/10.1186/ar4175 |
Ejemplares similares
-
The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2001) -
Potential Strategies in the Prevention of Nonsteroidal Anti-inflammatory Drugs-Associated Adverse Effects in the Lower Gastrointestinal Tract
por: Guo, Chuan-Guo, et al.
Publicado: (2020) -
Preventive Efficacy and Safety of Rebamipide in Nonsteroidal Anti-Inflammatory Drug-Induced Mucosal Toxicity
por: Kim, Jeong Ho, et al.
Publicado: (2014) -
Consensus about managing gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs?
por: Yeomans, Neville D
Publicado: (2015) -
Prevalence of gastrointestinal lesions in dogs chronically treated with nonsteroidal anti‐inflammatory drugs
por: Mabry, Kasey, et al.
Publicado: (2021)